| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 1.298 | 41.080 | 79.012 | 148.500 | 208.433 | 154.717 | 145.607 |
| Total Income - EUR | - | - | - | 1.298 | 41.080 | 79.016 | 148.504 | 209.347 | 158.811 | 153.362 |
| Total Expenses - EUR | - | - | - | 2.667 | 24.247 | 40.646 | 68.595 | 151.490 | 129.871 | 150.511 |
| Gross Profit/Loss - EUR | - | - | - | -1.369 | 16.833 | 38.369 | 79.909 | 57.857 | 28.941 | 2.851 |
| Net Profit/Loss - EUR | - | - | - | -1.408 | 16.422 | 37.617 | 78.424 | 56.085 | 27.626 | -873 |
| Employees | - | - | - | 0 | 2 | 3 | 3 | 4 | 5 | 5 |
Check the financial reports for the company - Caracostea Medical S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 1.053 | 1.712 | 6.413 | 64.665 | 251.100 | 342.836 | 311.831 |
| Current Assets | - | - | - | 1.123 | 14.523 | 32.905 | 81.408 | 19.805 | 18.369 | 4.729 |
| Inventories | - | - | - | 0 | 0 | 146 | 9.664 | 1.212 | 0 | 0 |
| Receivables | - | - | - | 755 | 4.969 | 4.308 | 60.439 | 16.430 | 17.740 | 4.350 |
| Cash | - | - | - | 367 | 9.554 | 28.451 | 11.305 | 2.164 | 629 | 379 |
| Shareholders Funds | - | - | - | -1.365 | 15.083 | 37.673 | 78.673 | 57.112 | 84.564 | 83.219 |
| Social Capital | - | - | - | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | 3.541 | 1.151 | 1.644 | 67.400 | 213.794 | 276.641 | 233.341 |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Caracostea Medical S.r.l.